Study Summary
This trial will test if 6D-MRI can help predict outcomes for pancreatic cancer patients.
Eligible Conditions
- Pancreatic Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: 2 years
2 years
Number of participants with R0 resection
Rate of progression-free survival from baseline
Baseline, 2 years
Change in functional status from baseline, as measured by the Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status
Change in overall health from baseline, as measured by the Charlson Comorbidity Index (CCI)
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
6D-MRI
1 of 1
Experimental Treatment
36 Total Participants · 1 Treatment Group
Primary Treatment: 6D-MRI · No Placebo Group · N/A
6D-MRI
DiagnosticTest
Experimental Group · 1 Intervention: 6D-MRI · Intervention Types: DiagnosticTestTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
456 Previous Clinical Trials
154,199 Total Patients Enrolled
Stephen Pandol, MDPrincipal Investigator - Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
1 Previous Clinical Trials
24 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have access to a device that can sync to the Fitbit.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments